PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $62,000 | -58.1% | 12,178 | -49.1% | 0.00% | – |
| Q2 2019 | $148,000 | +42.3% | 23,945 | -2.9% | 0.00% | – |
| Q4 2018 | $104,000 | +42.5% | 24,654 | +112.5% | 0.00% | – |
| Q3 2018 | $73,000 | -79.9% | 11,600 | -76.2% | 0.00% | -100.0% |
| Q1 2018 | $363,000 | +397.3% | 48,685 | +296.0% | 0.00% | – |
| Q4 2017 | $73,000 | -24.0% | 12,294 | -5.7% | 0.00% | – |
| Q3 2017 | $96,000 | -79.8% | 13,032 | -74.2% | 0.00% | -100.0% |
| Q1 2017 | $476,000 | +406.4% | 50,488 | +133.3% | 0.00% | +100.0% |
| Q1 2016 | $94,000 | -14.5% | 21,640 | +20.8% | 0.00% | 0.0% |
| Q4 2015 | $110,000 | -29.9% | 17,920 | -14.9% | 0.00% | 0.0% |
| Q2 2015 | $157,000 | -30.5% | 21,052 | -51.7% | 0.00% | -50.0% |
| Q3 2014 | $226,000 | +218.3% | 43,559 | +163.3% | 0.00% | +100.0% |
| Q2 2014 | $71,000 | – | 16,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |